ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.463,78
0,58%
S&P 500
5.347,22
-0,25%
US Dollar vs BRL
5,3437
-0,20%
Bitcoin
67.007,20
-3,60%
Brent Oil
81,505
-0,33%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Targanta Therapeutics Corp (MM) (TARG)

  7. Targanta Therapeutics Corp (MM) (TARG) Notícias

TARG

Targanta Therapeutics Corp (MM) (TARG)

Targanta Therapeutics Corp (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TARG
DataHoraFonteTítuloCódigoCompanhia
26/02/200908:06Edgar (US Regulatory)(25-NSE)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200912:50Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200912:05Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200912:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200910:30MarketwiredThe Medicines Company Announces Completion of Tender Offer for Shares of Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
20/02/200909:58Business WireTarganta Enters into Memorandum of Understanding to Resolve Shareholder LawsuitNASDAQ:TARGTarganta Therapeutics Corp (MM)
17/02/200918:12Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200917:43Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200916:08MarketwiredThe Medicines Company Commences Tender Offer for All Outstanding Shares of Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200915:54Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200909:04Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200909:01Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
22/01/200919:49Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:TARGTarganta Therapeutics Corp (MM)
14/01/200920:20Edgar (US Regulatory)Current report filing (8-K)NASDAQ:TARGTarganta Therapeutics Corp (MM)
13/01/200901:34MarketwiredThe Medicines Company to Acquire Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
18/12/200819:05Business WireTarganta Announces Corporate RestructuringNASDAQ:TARGTarganta Therapeutics Corp (MM)
09/12/200802:52Business WireFDA Issues Complete Response Letter for OritavancinNASDAQ:TARGTarganta Therapeutics Corp (MM)
03/12/200809:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/11/200817:49Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:TARGTarganta Therapeutics Corp (MM)
24/11/200813:32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TARGTarganta Therapeutics Corp (MM)
20/11/200800:17Business WireFDA Advisory Committee Provides Opinion on Oritavancin for the Treatment of Complicated Skin and Skin Structure InfectionsNASDAQ:TARGTarganta Therapeutics Corp (MM)
18/11/200812:52Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:TARGTarganta Therapeutics Corp (MM)
17/11/200815:29Business WireTarganta Announces Posting of Briefing Documents for Review of FDA Anti-Infective Drugs Advisory Committee Meeting for Oritav...NASDAQ:TARGTarganta Therapeutics Corp (MM)
12/11/200811:02Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:TARGTarganta Therapeutics Corp (MM)
12/11/200810:58Business WireTarganta Reports Third-Quarter 2008 Financial ResultsNASDAQ:TARGTarganta Therapeutics Corp (MM)
05/11/200810:58Business WireTarganta Therapeutics to Present at November 2008 Investor ConferencesNASDAQ:TARGTarganta Therapeutics Corp (MM)
26/10/200814:15Business WireTarganta Presents Efficacy & Safety Data for Oritavancin for the Treatment of Gram-Positive Complicated Skin & Skin Structure...NASDAQ:TARGTarganta Therapeutics Corp (MM)
26/10/200813:15Business WireTarganta Therapeutics Presents Data on Mechanisms That Underly Oritavancin’s Bactericidal ActivityNASDAQ:TARGTarganta Therapeutics Corp (MM)
25/10/200814:15Business WireTarganta Presents Preclinical In Vivo Data Demonstrating Activity of Oritavancin against Clostridium Difficile InfectionNASDAQ:TARGTarganta Therapeutics Corp (MM)
25/10/200814:15Business WireTarganta Therapeutics Presents In Vitro Data Highlighting Oritavancin’s Potent Activity Against Gram-Positive PathogensNASDAQ:TARGTarganta Therapeutics Corp (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:TARG

Seu Histórico Recente

NASDAQ
CXPO
LSE
JH68
Citi Fun 25
ASX
RCB
Russell Investments
NASDAQ
WSCACX
Small Cap Value Fund Fee...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados